🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lifecore Biomedical, Inc.

LFCR Healthcare
$5.81 +$0.15 (2.65%)
Market Cap: $217.55 M
Gurus Holding
4
Popularity Rank
#2180
% of Shares Held
0.42%
Net Activity (Q1 2026)
+$156,128.22

Guru Ownership Trend

Guru Analysis for Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical, Inc. (LFCR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $915,638.57.

Top institutional holders include Mario Gabelli and Jefferies Group.

Institutional sentiment is currently Bullish. This is evidenced by a $156,128.22 net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Cliff Asness reduced exposure by 1.9%.

Key Holders

Top 5 by Value

$311,736
$120,900
$94,588
$59,037

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$157,247.95
Total Buy Value
New Buys 1
Additions 1
-$1,119.73
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Lifecore Biomedical, Inc. (LFCR)

Major holders include Mario Gabelli ($311,736), Jefferies Group ($120,900), Steven Cohen ($94,588). According to the latest reported data, 4 tracked investment managers collectively hold approximately 157,597 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $156,128.22, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited LFCR. The total reported sell value was $1,119.73.

Yes, 1 managers opened new positions in LFCR, and 1 increased their existing holdings. The total reported buy value was $157,247.95.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% 83,800 $311,736 Q1 2026
0.00% New Buy 32,500 $120,900 Q1 2026
0.00% Add 62.4% 25,427 $94,588 Q1 2026
0.00% Reduce -1.9% 15,870 $59,037 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form